Go offline with the Player FM app!
New Treatment Option for Spinal Muscular Atrophy with Dr. Greg Rippon Genentech TRANSCRIPT
Manage episode 288340951 series 99915
Dr. Greg Rippon, Vice President and Chief Medical Partner of Neurology, Genentech shines light on SMA, spinal muscular atrophy, a severe inherited progressive neuromuscular disease and one of the most common rare diseases affecting babies. With the introduction of Evrysdi to the treatment options for SMA, an oral treatment is being tested to increase the production of the functional survival motor neuron protein and thus benefit patients in their motor functioning.
@genentech #genentech #SMA #SpinalMuscularAtrophy #Evrysdi #raredisease
1733 episodes
Manage episode 288340951 series 99915
Dr. Greg Rippon, Vice President and Chief Medical Partner of Neurology, Genentech shines light on SMA, spinal muscular atrophy, a severe inherited progressive neuromuscular disease and one of the most common rare diseases affecting babies. With the introduction of Evrysdi to the treatment options for SMA, an oral treatment is being tested to increase the production of the functional survival motor neuron protein and thus benefit patients in their motor functioning.
@genentech #genentech #SMA #SpinalMuscularAtrophy #Evrysdi #raredisease
1733 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.